Dr. Michael Fulks comments on the results of a recent study of Donanemab, an antibody that targets the amyloid-β (Aβ)… Read More
Welcome to the CRL Insurer Services blog. From big data and insurtech to accelerated underwriting and self-service products, the world of life insurance is moving at an unprecedented pace. We are confident that mortality data and insurance industry capabilities will continue to evolve, and seek to provide relevant expertise and updates to our valued clients.
As we continue to provide lab, data, and underwriting services through the CRL Insurers Business Unit, we look forward to sharing updates with you here. Check out the latest posts below from our dedicated team of medical directors and industry leaders, who provide commentary on timely topics, innovative services and solutions, and the existing database of CRL expertise.